FUN

5-(AMINOSULFONYL)-4-CHLORO-2-[(2-FURYLMETHYL)AMINO]BENZOIC ACID

FUN is found in 3 entries.

FUN as free ligands, exist in 3 entries. Examples include 2XN5 1Z9Y 3RF4

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo



Chemical Component Summary

Name 5-(AMINOSULFONYL)-4-CHLORO-2-[(2-FURYLMETHYL)AMINO]BENZOIC ACID
Identifiers 4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoyl-benzoic acid
Formula C12 H11 Cl N2 O5 S
Molecular Weight 330.744  g/mol
Type NON-POLYMER
Isomeric SMILES NS(=O)(=O)c1cc(C(O)=O)c(NCc2ccco2)cc1Cl
InChI InChI=1S/C12H11ClN2O5S/c13-9-5-10(15-6-7-2-1-3-20-7)8(12(16)17)4-11(9)21(14,18)19/h1-5,15H,6H2,(H,16,17)(H2,14,18,19)
InChIKey ZZUFCTLCJUWOSV-UHFFFAOYSA-N

Chemical Details

Formal Charge 0
Atom Count 32
Chiral Atom Count 0
Chiral Atoms n/a
Bond Count 33
Aromatic Bond Count 11
Leaving Atoms n/a

Drug Info: DrugBank

DrugBank ID DB00695   (Stereoisomeric match)
Name Furosemide
Groups approved
Description A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for edema and chronic renal insufficiency. [PubChem]
Synonyms
  • 2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid
  • 4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid
  • 4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid
  • 4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid
  • Frusemide
Brand Names
  • Apo Furosemide Tab 20mg
  • Apo Furosemide Tab 40mg
  • Apo Furosemide Tab 80mg
  • Ava-furosemide
  • Bio-furosemide
Affected Organism Humans and other mammals
Indication For the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Also for the treatment of hypertension alone or in combination with other antihypertensive agents.
Pharmacology Furosemide, a sulfonamide-type loop diuretic structurally related to bumetanide, is used to manage hypertension and edema associated with congestive heart failure, cirrhosis, and renal disease, including the nephrotic syndrome.
Mechanism of action Furosemide, a loop diuretic, inhibits water reabsorption in the nephron by blocking the sodium-potassium-chloride cotransporter (NKCC2) in the thick ascending limb of the loop of Henle. This is achieved through competitive inhibition at the chloride binding site on the cotransporter, thus preventing the transport of sodium from the lumen of the loop of Henle into the basolateral interstitium. Consequently, the lumen becomes more hypertonic while the interstitium becomes less hypertonic, which in turn diminishes the osmotic gradient for water reabsorption throughout the nephron. Because the thick ascending limb is responsible for 25% of sodium reabsorption in the nephron, furosemide is a very potent diuretic.
Route of administration
  • intramuscular; intravenous
  • intravenous
  • oral
Categories
  • Diuretics
  • Sodium Potassium Chloride Symporter Inhibitors
ATC-Code C03CA01
AHFS-Code 40:28.08
CAS number 54-31-9
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID: 21059682